Table 1 Patient and tumour characteristics

From: A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

No. of patients

36

Median age (range)

62 years (36–82)

Gender

 

 Male

27

 Female

9

ECOG performance status

 0

15

 1

18

 2

3

Clinical staging

 

 T2

4

 T3

26

 T4

5

 n.a.

1

 cN 0

4

 cN +

31

 n.a.

1

Distant metastases

 Resectable (liver)

2

 Supected (pleura, irresectable)

1

Distance from lower tumour margin to anal verge

 Median

5 cm

 Range

2–15 cm

 0–5 cm

21

 >5–10 cm

9

 >10 cm

5

 NA

1